Physician profile
Debra L Schell
NPI 1437199940
$1,002.24
in general payments reported to CMS, 2019-2025
12 companies · $54.55 in 2025
The $54.55 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $47.82 · 2022: $231 · 2023: $391 · 2024: $128 · 2025: $54.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $491 · Education: $83.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $490.68 |
| Education | $83.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $314.59 | 2022-2025 | Menopur, Endometrin |
| Vitrolife INC. | $187.54 | 2023 | |
| Ferring Pharmaceuticals As | $126.88 | 2022 | |
| Organon LLC | $105.96 | 2022-2024 | Follistim Aq |
| Therapeuticsmd, INC. | $59.05 | 2019-2020 | |
| Hologic Sales and Service, LLC | $49.81 | 2024-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Omni Hysteroscope |
| Pfizer INC. | $38.83 | 2019-2020 | |
| Abbvie INC. | $36.00 | 2019 | |
| Roche Diagnostics Corporation | $26.88 | 2019 | |
| Lupin INC. | $22.04 | 2019 | |
| Emd Serono, INC. | $19.67 | 2022 | |
| Allergan, INC. | $14.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Schell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.